← Back to Search

Education + Patient Navigation for Cancer Screening (NYC CONNECT Trial)

N/A
Recruiting
Led By Chau Trinh, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to month 6
Awards & highlights

NYC CONNECT Trial Summary

This trial will compare the effectiveness of two methods to get more people screened for breast, cervical, and colorectal cancer: one with tailored education and community health workers, and one with tailored education only. All participants will get help with social needs.

Who is the study for?
This trial is for English, Spanish, Haitian-Creole, or Chinese Mandarin speakers in specific NYC areas who are due for breast, cervical, or colorectal cancer screenings. Women should be 21-75 years old and men 50-75. Exclusions include those with total colectomy, current cancer navigation program participants, hospice care patients, certain advanced illnesses or long-term institution residents over 66 years old.Check my eligibility
What is being tested?
The study compares two methods to increase cancer screening rates: one uses tailored educational materials plus community health worker-led patient navigation (PN), while the other provides just the educational materials (less intensive). Participants will also receive help for unmet social needs.See study design
What are the potential side effects?
Since this trial involves educational materials and patient navigation services rather than medical treatments or drugs, there are no direct physical side effects associated with these interventions.

NYC CONNECT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of Participants who Receive at Least 1 Cancer Screening at 6 Months After Study Enrollment

NYC CONNECT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Patient Navigation (PN)Experimental Treatment2 Interventions
Participants randomized to the PN arm will receive community health worker (CHW)-administered PN for cancer screening + social service needs + culturally and linguistically tailored cancer education. All individuals will complete a survey at baseline, 3 months, and 6 months.
Group II: Less Intensive (LI)Active Control2 Interventions
Participants randomized to LI arm will receive PN to social service needs + culturally and linguistically tailored cancer education materials. All individuals will complete a survey at baseline, 3 months, and 6 months. Once a participant randomized to the LI arm completes the 6-month survey, they will have the option to receive all navigational support provided by CHWs to individuals randomized to the PN arm.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Educational Materials
2013
N/A
~16390

Find a Location

Who is running the clinical trial?

Centers for Disease Control and PreventionFED
875 Previous Clinical Trials
22,475,242 Total Patients Enrolled
1 Trials studying Cancer Screening
1,707 Patients Enrolled for Cancer Screening
NYU Langone HealthLead Sponsor
1,369 Previous Clinical Trials
838,438 Total Patients Enrolled
Chau Trinh, PhDPrincipal InvestigatorNYU Langone Health

Media Library

Patient Navigation (PN) - Less Intensive Clinical Trial Eligibility Overview. Trial Name: NCT05742178 — N/A
Cancer Screening Research Study Groups: Patient Navigation (PN), Less Intensive (LI)
Cancer Screening Clinical Trial 2023: Patient Navigation (PN) - Less Intensive Highlights & Side Effects. Trial Name: NCT05742178 — N/A
Patient Navigation (PN) - Less Intensive 2023 Treatment Timeline for Medical Study. Trial Name: NCT05742178 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial open to individuals who have surpassed the age of thirty?

"Prospective patients must meet specific criteria to be considered for inclusion - they should not exceed 75 years of age and, at minimum, need to have turned 21."

Answered by AI

Are there any specific characteristics which make a person an ideal participant for this research?

"To be eligible for this medical experiment, prospective patients must have proof of cancer screening and fit between the ages of 21-75. This research effort is currently seeking 2160 participants."

Answered by AI

Is this experiment recruiting participants at the present time?

"Clinialtrials.gov indicates that the trial, which was initially posted on April 1st 2023 and recently updated on February 15th 2023, is not currently accepting patient applications. Nonetheless, three other studies are actively recruiting participants at this time."

Answered by AI

Who else is applying?

What site did they apply to?
NYU Langone Health
What portion of applicants met pre-screening criteria?
Did not meet criteria

Why did patients apply to this trial?

cancer screening No health insurance.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation
2023. "NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05742178.
~1440 spots leftby Oct 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top